Cerebral Immunohistochemical Characterization of the H2S and the Oxytocin Systems in a Porcine Model of Acute Subdural Hematoma

The hydrogen sulfide (H₂S) and the oxytocin/oxytocin receptor (OT/OTR) systems interact in trauma and are implicated in vascular protection and regulation of fluid homeostasis. Acute brain injury is associated with pressure-induced edema formation, blood brain barrier disruption, and neuro-inflammation. The similarities in brain anatomy: size, gyrencephalic organization, skull structure, may render the pig a highly relevant model for translational medicine. Cerebral biomarkers for pigs for pathophysiological changes and neuro-inflammation are limited. The current study aims to characterize the localization of OT/OTR and the endogenous H₂S producing enzymes together with relevant neuro-inflammatory markers on available porcine brain tissue from an acute subdural hematoma (ASDH) model. In a recent pilot study, anesthetized pigs underwent ASDH by injection of 20 mL of autologous blood above the left parietal cortex and were resuscitated with neuro-intensive care measures. After 54 h of intensive care, the animals were sacrificed, the brain was removed and analyzed via immunohistochemistry. The endogenous H₂S producing enzymes cystathionine-ɤ-lyase (CSE) and cystathionine-β-synthase (CBS), the OTR, and OT were localized in neurons, vasculature and parenchyma at the base of sulci, where pressure-induced injury leads to maximal stress in the gyrencephalic brain. The pathophysiological changes in response to brain injury in humans and pigs, we show here, are comparable. We additionally identified modulators of brain injury to further characterize the pathophysiology of ASDH and which may indicate future therapeutic approaches.

Introduction

Recently we described a long-term (54 h) resuscitated porcine model of acute subdural hematoma (ASDH)-induced acute brain injury, which comprised elevated intracranial pressure (ICP), and morphological damage without major neurological dysfunction, due to the neuro-intensive care maintenance of cerebral perfusion pressure (CPP) and tissue oxygen (PbtO₂) (1).

In spite of many promising results with rodent acute brain injury models, translation into benefits for the clinic seems problematic (2). This may at least in part be due to the fact that rodents have lissencephalic brains, whereas humans have gyrencephalic brains (3, 4). Gyrencephalic brains are more susceptible to pressure-induced acute brain injury, because in the gyrencephalic brain the maximal mechanical pressure occurs at the base of the sulci, whereas the lissencephalic brain structure of the rodent brain allows for the pressure elevation to be distributed more evenly (2, 5). The pig as a model organism entails various advantageous similarities to humans regarding the brain: size, gyrencephalic neuroanatomical organization, skull structure, and proportion of white matter to gray matter (2, 5). The skull and tentorium cerebelli of pigs and humans have similar rigid characteristics in contrast to rodents, which only have a “vestigial connective tissue membrane” (2). The rigidity of the tentorium cerebelli, which separates the cerebrum from the cerebellum, is significant in confining the injury-induced edema formation and increase in ICP following acute brain injury, which mostly occurs in the cerebrum in humans and pigs (2). Furthermore, the adult pig and human brain are composed of 60% white matter, in contrast to <12% in the adult rat brain (5). This may be crucial for translation since white matter is more prone to develop edema and thus aggravates the pressure-induced trauma in the cerebrum (2, 6).

Hydrogen sulfide (H₂S), a gaseous mediator, and the oxytocin (OT)/oxytocin receptor (OTR) system are implicated in fluid homeostasis and may play a role in edema (7). Their interaction has been reported in trauma (8, 9). In our porcine ASDH pilot study, markers of blood brain barrier (BBB) dysfunction and oxidative and nitrosative stress, were significantly elevated in the ipsilateral side, i.e., the side of ASDH induction. Since both H₂S and the OT/OTR systems have been reported to play a role as anti-oxidants and in vascular protection, they could be relevant players in ASDH (10–13).

Immunohistochemical studies in porcine acute brain injury are limited (2, 14–20). In particular, the cell-specific cerebral localization and distribution of the endogenous H₂S producing enzymes, OT and OTR in association with mediators of injury are not reported. Thus, information on protein localization in the global landscape of the brain, which is not assessable otherwise, is clearly lacking (21).

Therefore, the aim of the present study is to further characterize, immunohistochemically, the spatial protein expression of OTR, OT and the H₂S producing enzymes and assessing potential mediators for porcine acute brain injury in the available material from our ASDH pilot study (1).

Materials and Methods

The study was approved by the Federal Authorities for Animal Research and the local Animal Care Committee (Reg.-Nr. 1316, date of approval June 20, 2016). All experiments were conducted in adherence with the National Institute of Health Guidelines on the Use of Laboratory Animals and the European Union “Directive 2010/63/EU on the protection of animals used for scientific purposes.” This is an immunohistochemical study performed on available brain sections from a recently published porcine model of ASDH (1): 5 female and 4 male (castrated) anesthetized Bretoncelles-Meishan-Willebrand pigs (age 11 months, 65 kg). IHC allowed us to study and visualize the nuclear or cytoplasmic protein localization in the global landscape of the brain. In contrast to techniques which only use homogenized tissue, e.g., western blot, immunohistochemistry (IHC) allowed for detecting the spatial expression patterns and distinguishing between tissue and blood, a common confounding factor in homogenized tissue (22). We used a colorimetric detection system which allows us to visualize the tissue architecture and cellular morphology (limited in immunofluorescence), e.g., vacuolization or necrosis.

Anesthesia, surgical procedures and resuscitation were described in detail previously (1) ASDH was induced by injection of 20 mL of autologous blood via a subdural catheter above the left parietal cortex. Therefore, the skull was exposed and a craniotomy was performed by drilling a hole over the left and right parietal cortex and a small incision of the dura was made. According to the 3R principle the right hemisphere was also instrumented to avoid the need for additional sham experiments. Microdialysis catheters and multimodal brain monitoring probes were inserted in both hemispheres of brain parenchyma (1).

Two hours after ASDH induction, resuscitation was initiated: CPP was titrated to baseline pressure (if not sufficient norepinephrine was used), neuro-intensive care measures were in accordance with the current guidelines of traumatic brain injury (TBI) management in an effort to further improve clinical translation of novel therapeutic interventions (23). After 54 h of intensive care, anesthesia was further deepened and pigs were sacrificed via injection of potassium chloride.

Immunohistochemistry

Immediately after termination of the experiment the brain was removed, cut sagittally to separate the hemispheres and fixed in 4% formalin. After 6 days of fixation (fixation identical for all samples) the brain was cut from frontal to occipital into consecutive 4 mm thick macroscopic sections (13–17 sections in total), dehydrated, and embedded in paraffin blocks (1).

Available brain sections for further IHC included frontal, medial and occipital (limited, brainstem and cerebellum) regions from the ipsi- and contralateral side. Paraffin sections were cut (3–5 μm), deparaffinized in xylene, and rehydrated with a graded series of ethanol and deionized water. Heat-induced antigen retrieval was performed by bringing the samples to a boil in a microwave oven in a 10 mM citrate solution (pH 6) and cooling back to room temperature. All the following steps were performed at room temperature. Blocking with normal goat serum (10%) for 20–30 min was performed before 1 h primary antibody incubation with: endogenous H₂S producing enzymes anti-cystathionine-ɤ-lyase (CSE) (Protein Tech, 12217-1-AP) and anti-cystathionine-β-synthase (CBS) (Protein Tech, 14787-1-AP), anti-OT (Millipore, AB911), anti-OTR [Protein Tech, 23045-1-AP (10)]. Further mediators of injury were investigated by using the following primary antibodies: anti-pig albumin (Alb) (Abcam, ab79960) (1); anti-aquaporin 4 (AQP4) (Protein Tech, 16473-1-AP); anti-neuronal nuclei (NeuN) (Cell signaling, 24307) as a marker for neurons; anti-complement component 5a receptor (C5aR) (Protein Tech, 21316-1-AP); anti-induced complement component 3 (iC3) (Hycult biotech, HM2168); anti-complement component 1 Q subcomponent-binding protein (C1QBPBP) (Protein Tech, 24474-1-AP); anti-interleukin 6 receptor (Il-6R) (Protein Tech, 23457-1-AP); anti-tumor necrosis factor receptor 1 and 2 (TNFR1 (Protein Tech, 21574-1-AP) and TNFR2 (Protein Tech, 19272-1-AP). Sections of ipsi- and contralateral brain specimens were analyzed concurrently, and negative controls were performed (examples see Figure S1). Since the IHC detection of OTR in the brain has proven to be a particular challenge in the past, the specificity of the OTR antibody used in this study was validated by both negative controls [knock out (9)] and positive controls, western blot and immunoprecipitation (Proteintech, methods description and results in Figure S2). The specificity of the antibodies has been additionally confirmed in NCBI BLAST searches (courtesy of the U.S. National Library of Medicine). The BLAST “finds regions of similarities between biological sequences, and compares protein sequences to sequence databases.” We compared immunogen sequences of the used antibodies to the sus scrofa database (see Table 1). When the immunogen sequence was not available we used the full length protein sequence of the species the antibody was made to, in this case human. A query cover above 90% and homology above 60% were investigated, when there was no significant homology to any other protein.

TABLE 1

Table 1. Protein BLAST search for primary antibodies (anti-human) to sus scrofa.

Detection of primary antibodies was performed according to the manufacturer's instructions using the Dako REAL detection system (based on alkaline phosphatase conjugated secondary antibodies: anti-mouse, anti-rabbit), and visualized with red chromogen followed by counterstaining with Mayer's hematoxylin (1, 12, 24). Slides were visualized using a Zeiss Axio Imager A1 microscope with 2.5X, 10X, 20X. and 40X objectives.

Results

The pictures in the following figures are representative examples of all the IHC experiments for each protein of interest, performed on tissue from various animals. The exact number of animals are given in the figure legends.

Cytoplasmic OTR expression was found in cortical neurons in both hemispheres of the frontal cortex (see Figures 1A1,B1). OTR and OT expression was present in the parenchyma around the sulci of the ipsilateral side (see Figures 1A,C). Specifically, we observed an OTR positive lining around the nucleus of small cells in the white matter. Sections from the ASDH induction site showed OTR expression in and around the parenchyma of necrotic areas (associated with loss of cellular architecture/vacuolization). Hippocampal neurons and granular neurons showed OTR and OT expression, primarily in the cytoplasm. Perivascular swelling was associated with more parenchymal OTR expression (see Figure 1A1).

FIGURE 1

Figure 1. Comparison of OTR (A,B, n = 6), OT (C,D, n = 7), CSE (E,F, n = 7), and CBS (G,H, n = 6) expression in matching consecutive sections of a sulcus of the frontal cortex [ipsilateral (A,C,E,G) vs. contralateral side (B,D,F,H)]. Macroscopic exemplary sections are shown at the top (open arrows pointing to sulci). Ipsilateral OTR expression in the pial vasculature and glia limitans with blushing effect in the parenchyma surrounding the base of the sulcus (A), cortical neurons magnified in (A1), less pronounced OTR expression on the contralateral site (B), cortical neurons magnified in (B1). OT expression is more limited than OTR expression but shows the same expression pattern as OTR in the ipsi- (C, magnified in C1) and contralateral side (D, magnified in D1). In the ipsilateral side CSE is pronouncedly expressed surrounding the sulcus and negative in the parenchyma moving away from the sulcus (E) and shows little to no expression in cortical neurons, with nuclear counter-staining with hematoxylin (black arrows magnified in E1). CSE is expressed in the pial vasculature and is evenly distributed in parenchyma of the contralateral side around the sulcus (F) with (red) CSE-positive cortical neurons (black arrow heads magnified in F1). In the ipsilateral side CBS shows pronounced expression surrounding the sulcus (G) and is not expressed in cortical neurons (magnified in G1). CBS expression in the contralateral side is weak (H) and present in the microvasculature (magnified in H1). OTR: oxytocin receptor; OT, oxytocin; CSE, cystathionine-ɤ-lyase; CBS, cystathionine-β-synthase.

CSE was expressed in cortical neurons (cytoplasmic) of the frontal cortex in the contralateral side (see Figure 1F1) and low in the ipsilateral side (see Figure 1E) confined to the sulci. CSE was also expressed in hippocampal neurons and granular neurons. At the injury site, CSE was present in necrotic areas where parenchymal bleeding was present and tissue architecture was disrupted (CSE potentially coming from the circulation/blood). There was little CBS expression in the parenchyma of the contralateral side (see Figure 1H). In the ipsilateral side CBS was strongly expressed around the sulcus (see Figure 1G) and not expressed in cortical neurons (see Figure 1G1).

At the ASDH site, the parenchyma of necrotic areas with vacuolization (see Figure 2A), and singular neurons (see Figure 2B) were positive for Alb. However, the majority of the neurons were negative for Alb (see Figure 2C). Distant to the injury in midbrain subcortical regions, neurons were positive for Alb expression (see Figures 2D–F). Interestingly, in the hippocampus we found nuclear localization of Alb (see Figures 2G,H).

FIGURE 2

Figure 2. Alb expression in the ipsi- (A–C, midbrain cortical region) and contralateral (D–G, midbrain subcortical region) side (n = 9). Alb expression at the ASDH site (ipsilateral): extensive Alb extravasation (A), singular neurons around the ASDH site are positive for Alb (black arrow heads B), most cortical neurons were negative for Alb (black arrows C). Alb expression in the contralateral hemisphere (distant to the ASDH site): minor Alb extravasation from microvasculature (indicated by positive adventitia of microvasculature (arrow head) and parenchyma), cytoplasmic positive neurons around vacuolization (black arrows D), pial artery SMCs negative, positive adventitia (arrow head), positive neurons associated with swelling (black arrows E), Alb contained in neurons and inside the microvasculature (black arrows F), hippocampal neurons show nuclear Alb expression (G) magnified in (H), see black arrow. ASDH, acute subdural hematoma; Alb, albumin; SMCs, smooth muscle cells.

We established the staining of AQP4, a water channel protein, in the pig brain (parietal cortex). AQP4 shows variable expression as we move away from the injury site to the morphologically intact tissue (see Figures 3A–C).

FIGURE 3

Figure 3. AQP4 expression in the parietal cortex at the injury site (A), in neighboring areas (B) and distant to the injury site (C) (n = 6). At the injury site cellular architecture is impaired and AQP4 expression is weak (A), moving away from the injury there is more AQP4 expression (B), maximal AQP4 expression is present distant to the injury (C). AQP4, aquaporin 4.

In the frontal cortex, NeuN was strongly expressed in the intact regions (see Figure 4B), and its expression was lower in neurons near the injury site (see Figure 4A).

FIGURE 4

Figure 4. NeuN expression in cortical neurons of the frontal cortex close to (A) and further away (B) from the injury site (n = 6). Cortical neurons show little to no expression of NeuN in proximity to the injury (A), in distance to the injury cortical neurons show NeuN expression (B). NeuN, neuronal nuclei.

Vasculature

Pial arteries expressed OTR and OT in the smooth muscle cells (SMCs) and in the endothelium (see Figures 1A–D). Around pial and microvascular arteries there was a OTR and OT positive “blushing” expression pattern around sulci of the frontal cortex in the ipsilateral hemisphere (see Figures 1A,C). CSE was expressed in the SMCs of the pial arteries. In the microvasculature, CSE was expressed in vessel walls, mostly in the SMCs and the endothelium (see Figure 6B). In the microvasculature and pial arteries Alb was localized in the adventitia (see Figures 2D,E).

Inflammation

CSE positive immune cells were present in and around the microvasculature and pial arteries (see Figure 6B). OTR positive immune cells were present near the ruptured microvasculature. Cortical neurons of the parietal cortex showed nuclear positivity for C5aR in proximity and distant to the ASDH site (see Figure 5A4). Close to the injury site there was an infiltration of C5aR-expressing immune cells in areas of intraparenchymal bleeding (see Figure 5A1–3). In the brainstem, C5aR was mostly present in the cytoplasm, in contrast to the cortical region. Expression of iC3 was more limited in the parietal cortex in comparison to C5aR but also found in infiltrating immune cells and parenchyma (see Figure 5B1–3). In the hippocampus, granular neurons also expressed C5aR. C1QBP was positive in the cytoplasm of neurons around the ASDH site in the frontal cortex (see Figure 6A). C1QBP was detected associated with the microvasculature, strongly expressed in immune cells within the vessel wall and in areas of discrete bleeding (see Figure 6A,A1).

FIGURE 5

Figure 5. C5aR (A, n = 8) and iC3 (B, n = 7) expression around the ASDH site in four anatomical levels of the parietal cortex (A/B 1–3) and distant to the ASDH site (A/B 4). Around the ASDH site perivascular infiltration of C5aR positive immune cells (unfilled arrow heads A1–3), immune cell and parenchymal localization of iC3 (punctuated arrows B1–3), distant to the ASDH site nuclear expression of C5aR in cortical neurons (black arrow heads A4), no neuronal iC3 detection distant to the ASDH site (black arrows B4). C5aR, complement component 5a receptor; iC3, induced complement component 3; ASDH, acute subdural hematoma.

FIGURE 6

Figure 6. C1QBP (A, n = 5) and CSE (B, n = 7) expression in matching consecutive sections of the frontal cortex at the border zone of gray and white matter. Perivascular infiltration of C1QBP and CSE positive immune cells (unfilled arrow heads A,A1,B), C1QPB expression in the endothelium and SMCs of the microvascular artery (A) (vessel magnified in A1) and in the parenchyma with interstitial extravasated erythrocytes (A,A1). C1QBP and CSE in neurons (black arrow heads) (A,B magnified in B1). CSE expression in the arterial SMCs. White matter is negative for both: C1QBP and CSE (black arrows) (A,B). C1QBP, complement component 1 Q subcomponent-binding protein; CSE, cystathionine-ɤ-lyase; SMCs, smooth muscle cells.

Il-6R is predominantly expressed in the parenchyma and in the cytoplasm of neurons in areas with perivascular swelling in the parietal cortex (see Figure 7A). Close to the injury, immune cells in the parenchyma and in the microvasculature were Il-6R positive (see Figure 7A). Further away from the injury Il-6R expression was limited to neuronal cytoplasmic expression (see Figure 7B).

FIGURE 7

Figure 7. Il-6R expression in the parietal cortex in proximity (A) and distant to the injury (B) (n = 1). Il-6R expression in neurons, immune cells, parenchyma and the microvasculature close to the injury (A), and limited neuronal cytoplasmic expression distant to the injury (B). Il-6R, interleukin 6 receptor.

We only looked for TNFR1 and TNFR2 expression in the brainstem and the cerebellum, where the neurons showed cytoplasmic and nuclear TNFR1 and TNFR2 expression (see Figures 8A1,2,B1,2).

FIGURE 8

Figure 8. TNFR1 (A, n = 1) and TNFR2 (B, n = 1) in the brainstem (A/B 1) and in the cerebellum (A/B 2). In the brainstem TNFR1 (A1) and TNFR2 (B1) were expressed in neurons and microvasculature, and TNFR2 was also expressed in the parenchyma (B). In the cerebellum purkinje cells expressed TNFR1 (A2) and TNFR2 was expressed in purkinje, granular cells and parenchyma (B2). TNFR1, anti-tumor necrosis factor receptor 1; TNFR2, tumor necrosis factor receptor 2.

Discussion

In available brain tissue from a previous study describing a porcine ASDH model, we localized H₂S producing enzymes, as well as OTR and OT concurrent with markers of barrier dysfunction and local inflammation. The main findings were that CSE, CBS, OTR, and OT expression in the porcine brain were localized to: (i) cortical neurons in the gyri, (ii) in the parenchyma at the base of the sulci, (iii) microvasculature and pial arteries, and (iv) resident and infiltrating immune cells.

The cortical neurons in the gyri were positive for CSE (see Figure 1F1), but its expression was reduced in the ipsilateral side (see Figure 1E1), which may be related to the increased ICP. CSE was expressed and evenly distributed in the parenchyma of the contralateral side (see Figure 1F) and apparently lower in the ipsilateral side (see Figure 1E). CBS showed an opposite pattern and was not present in the contralateral hemisphere (see Figure 1H) but upregulated with injury immediately around the sulcus in the ipsilateral hemisphere (see Figure 1G), potentially due to the fact that the high ICP elicits the most stress at the base of the sulcus (2). This finding is particularly salient with regards to translational medicine, because in the gyrencephalic brain the pressure-induced injury is expected to be found distant to the surface at the depth of the sulci (2). This might also be related to a lack of tissue oxygenation, which commonly first occurs at the base of sulci, as observed in humans (25, 26). We see the same spatial reaction to injury found in humans in our pig model thus suggesting it may be an adequate model to study human brain injury (Figure 1). As shown in the inserts with high magnification of Figure 1, we observed perivascular swelling in both hemispheres, which agrees with TBI findings in humans showing “surrounding vasogenic edema within bilateral regions” (27).

Reports found in the literature on cerebral CSE expression are limited and ambiguous. Neuronal CSE mRNA and protein expression are reported in the cerebral cortex, in granular and purkinje cells in the cerebellum, and in pyramidal neurons in the hippocampus (28–30). In accordance with these findings, we detected CSE protein expression in hippocampal and cortical neurons in the contralateral hemisphere (see Figure 1F), in cerebellar punkinje cells and granular neurons. To our knowledge, this is the first report on cortical parenchymal CSE expression in gyri with constitutive expression in intact brain regions and reduced at the site of injury. CBS on the other hand, appears to be upregulated with injury (see Figure 1G). Its presence could not be detected in neurons (see Figures 1G1,H1), was variable in astrocytes and closely associated with the microvasculature, which is supported by the reports from the protein atlas (28, 31). In contrast to our findings, neuronal CBS expression has been reported in uninjured piglets, which may be more reflective of the developmental stage, whereas here, we analyzed adult pigs (32, 33). In fact, a study in humans revealed cerebral CBS expression pattern changes depending on age and neuronal damage (34).

We have reported the interaction of H₂S and the OTR in trauma (8) and H₂S can directly stimulate OT release on the hypothalamic level during fluid shifts and osmotic challenges (7, 35). OTR was abundantly expressed and OT less pronounced in cortical neurons and parenchyma around the base of the sulci, with increased expression in the ipsilateral side (see Figures 1A,C). The presence of OTR has been shown previously in human cortical neurons, in vascular profiles and around micro-infarcts in the gray and white matter, especially in activated astrocytes and vasculature (10, 36–38). This supports our findings of OTR and OT expression around the microvasculature in the ipsilateral hemisphere (see Figures 1A,C). These findings well agree with our previous results of the interaction between H₂S and the OT/OTR systems (8, 39): OTR and CBS were both upregulated as a response to pressure induced injury, whereas CSE showed the inverse response. Noteworthy, CSE, CBS, OTR and OT, all showed expression at the base of the sulci in the ipsilateral side, where maximal pressure-induced stress occurs in the gyrencephalic brain (see Figure 1).

Administration of H₂S has improved barrier integrity and reduced cerebral edema, and the loss of CSE expression has previously been associated with Alb extravasation and barrier dysfunction (11, 24, 40–42). Thus, the reduction of CSE on the ipsilateral side (see Figure 1E) might contribute to barrier dysfunction as evidenced by increased Alb extravasation (1).

Blood-borne protein and Alb uptake after BBB disruption has been shown to be accomplished by both astrocytes and neurons (43, 44). The presence of cerebral Alb leads to neuronal glutamate release into the extracellular matrix (43). Glucose and lactate levels are elevated as a consequence of injury and need to be cleared. Astrocytic glucose uptake and clearance is promoted by glutamate release from neurons which stimulates astrocytes to re-establish the extracellular milieu after trauma (45–47). We observed very few Alb positive neurons in the region of injury (see Figures 2A,B), and the majority of the cortical neurons in this area were negative for Alb (see Figures 2A,C). Interestingly, neuronal Alb was mostly present in the cytoplasm of morphologically normal cortical neurons distant to the ASDH (see Figures 2D–F). Intriguingly, in the hippocampus we found nuclear Alb staining in the neurons (see Figures 2G,H). Endogenous Alb production in the brain has been reported previously in response to injury, and is suggested to play a neuro-protective role (48, 49).

One of the limitations of the porcine model is the lack of established available biomarkers. The following are published key markers for the pig brain: 3-nitrotyrosine, NADPH oxidase subtype 2, glial fibrillary acidic protein (GFAP), ionized calcium-binding adapter molecule 1, microtubule-associated protein 2, β amyloid precursor protein, trefoil factor 3, brain-derived neurotrophic factor, Alb, CSE, CBS, OTR, and OT (1, 17–20, 32, 33, 37, 38, 50–52). Thus, we investigated the following additional markers to further characterize the ASDH model: AQP4, NeuN, C5aR, iC3 C1QPB, Il-6R, TNFR1, and TNFR2. The immunological markers were of particular interest because of the high homology of the innate immunity of the pig to the human: pigs are closer to the humans in 80% of the immune parameters investigated compared to rodents (53, 54).

AQP4 is the most abundant water channel protein in the human central nervous system (CNS) and is involved in edema and fluid homeostasis (55). We detected AQP4 in the pig brain and found that its expression was dependent on tissue integrity, declining with the severity of the injury and most abundant in intact tissue (see Figure 3).

NeuN was also found in the pig brain and serves as specific marker for post-mitotic neurons. The pattern of expression was similar to that described in humans after TBI wherein the strongest staining was found in regions with preserved cyto-architecture (see Figure 4) (56). To the best of our knowledge, this study is the first to identify porcine neurons with the neuronal marker NeuN.

Complement activation has been reported in CNS inflammation after acute brain injury, immune-mediated secondary neuropathology and BBB dysfunction (57–59). We detected C5aR (see Figure 5A1–3) positive immune cells and expression around the microvasculature which has been implicated in BBB dysfunction (60). We identified C5aR positive cortical neurons distant to the injury site (see Figure 5A4) which is in line with the literature on TBI (58), but there was no iC3 in neurons (see Figure 5B4). Presence of iC3 was detected in the parenchyma (see Figure 5B2) and around the immediate ASDH induction site, indicating complement activation.

C1QBP and CSE are shown around the ASDH induction site (see Figures 6A,B). The loss of CSE and the positive expression of C1QBP around the vessels (see Figure 6) may indicate a loss of the inhibitory function of H₂S on C1QBP (61).

Il-6R, a pro-inflammatory marker, was expressed in immune cells in the cerebral vasculature and neurons after injury (see Figures 7A,B) confirming the literature (62–64). We investigated two additional inflammatory markers: TNFR1 and TNFR2. Both antibodies tested worked in the pig brain: brainstem and cerebellum showed differential cytoplasmic and nuclear neuronal expression (see Figures 8A1,2,B1,2).

The purpose of the current study was to describe protein expression patterns in the porcine brain in a clinically relevant resuscitated ASDH model. An analysis of the functional consequences of the ASDH in this model has been reported in a previous publication (1). Any causal link between H₂S, OT/OTR and brain physiology, oxidative stress and inflammation was beyond the scope of the present study.

Conclusion

The H₂S, and the OT/OTR systems were shown to be expressed in the brain in a long-term, resuscitated porcine model of ASDH. In particular, they were identified in neurons, vasculature and parenchyma at the base of sulci, where pressure-induced injury leads to maximal stress in the gyrencephalic brain. We observed the same spatial relation to injury known for humans in our pig model suggesting it may be an appropriate model to study human brain injury. Cytoplasmic and nuclear presence of Alb was detected in morphological uninjured neurons distant from the ASDH induction site, which suggests an undescribed role for Alb after acute brain injury. We identified novel mediators of injury that can be used in the pig brain to further characterize the pathophysiology of ASDH and potential therapeutic approaches.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.

Ethics Statement

This study was approved by the Regierungspräsidium Tübingen (Germany) for Animal Research and the local Animal Care Committee (Reg.-Nr. 1316, date of approval June 20, 2016).

Author Contributions

ND performed the immunohistochemistry, data analysis and interpretation, and drafting of the manuscript. SU performed the immunohistochemistry. AH performed animal experiments and removal of the brain during the necropsy. AS performed the neuropathological evaluation and together with TM, EN, and MH-L helped with input for analysis of markers, data interpretation, critical comments, and expert feedback on the manuscript. CW and HG contributed critical comments and expert feedback on the manuscript. OM contributed to the experimental design, supervising immunohistochemistry, data interpretation, and writing of the manuscript. PR contributed to the study design and edited and approved the final version of the manuscript. All authors read and approved the final version of the manuscript.

Funding

Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project-ID 251293561 - Collaborative Research Center (CRC) 1149.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank Rosy Engelhardt, Andrea Seifritz, and Deborah Keller for their skillful technical assistance.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2020.00649/full#supplementary-material

References

1. Datzmann T, Kapapa T, Scheuerle A, McCook O, Merz T, Unmuth S, et al. In-depth characterization of a long-term, resuscitated model of acute subdural hematoma-induced brain injury. J Neurosurg. (2019). doi: 10.3171/2019.9.JNS191789. [Epub ahead of print].

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Vink R. Large animal models of traumatic brain injury. J Neurosci Res. (2018) 96:527–35. doi: 10.1002/jnr.24079

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Rosenfeld JV, Maas AI, Bragge P, Morganti-Kossmann MC, Manley GT, Gruen RL. Early management of severe traumatic brain injury. Lancet (London, England). (2012) 380:1088–98. doi: 10.1016/S0140-6736(12)60864-2

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Vink R, Bullock MR. Traumatic brain injury: therapeutic challenges and new directions. Neurotherapeutics. (2010) 7:1–2. doi: 10.1016/j.nurt.2009.12.001

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Kinder HA, Baker EW, West FD. The pig as a preclinical traumatic brain injury model: current models, functional outcome measures, and translational detection strategies. Neural Regen Res. (2019) 14:413–24. doi: 10.4103/1673-5374.245334

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Muñoz-Maniega S, Meijboom R, Chappell FM, Valdés-Hernández M, Starr JM, Bastin ME, et al. Spatial gradient of microstructural changes in normal-appearing white matter in tracts affected by white matter hyperintensities in older age. Front Neurol. (2019) 10:784. doi: 10.3389/fneur.2019.00784

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Ruginsk SG, Mecawi AS, da Silva MP, Reis WL, Coletti R, de Lima JB, et al. Gaseous modulators in the control of the hypothalamic neurohypophyseal system. Physiology (Bethesda, Md.). (2015) 30:127–38. doi: 10.1152/physiol.00040.2014

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Merz T, Lukaschewski B, Wigger D, Rupprecht A, Wepler M, Gröger M, et al. Interaction of the hydrogen sulfide system with the oxytocin system in the injured mouse heart. Intensive Care Med Exp. (2018) 6:41. doi: 10.1186/s40635-018-0207-0

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Wigger D, Gröger N, Lesse A, Krause S, Merz T, Gündel H, et al. Maternal separation induces long-term alterations in the cardiac oxytocin receptor and cystathionine γ-lyase expression in mice. Oxid Med Cell Longev. (2020) 2020:1–10. doi: 10.1155/2020/4309605

PubMed Abstract | CrossRef Full Text | Google Scholar

10. McKay EC, Beck JS, Khoo SK, Dykema KJ, Cottingham SL, Winn ME, et al. Peri-infarct upregulation of the oxytocin receptor in vascular dementia. J Neuropathol Exp Neurol. (2019) 78:436–52. doi: 10.1093/jnen/nlz023

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Stenzel T, Weidgang C, Wagner K, Wagner F, Gröger M, Weber S, et al. Association of kidney tissue barrier disrupture and renal dysfunction in resuscitated murine septic shock. Shock (Augusta, GA.). (2016) 46:398–404. doi: 10.1097/SHK.0000000000000599

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Merz T, Stenzel T, Nußbaum B, Wepler M, Szabo C, Wang R, et al. Cardiovascular disease and resuscitated septic shock lead to the downregulation of the H2S-producing enzyme cystathionine-γ-lyase in the porcine coronary artery. Intensive Care Med Exp. (2017) 5:17. doi: 10.1186/s40635-017-0131-8

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Işeri SO, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC. Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J Surg Res. (2005) 126:73–81. doi: 10.1016/j.jss.2005.01.021

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Meissner A, Timaru-Kast R, Heimann A, Hoelper B, Kempski O, Alessandri B. Effects of a small acute subdural hematoma following traumatic brain injury on neuromonitoring, brain swelling and histology in pigs. European surgical research. europaische chirurgische forschung. Recherches Chirurgicales Eur. (2011) 47:141–53. doi: 10.1159/000330756

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Nielsen TH, Engell SI, Johnsen RA, Schulz MK, Gerke O, Hjelmborg J, et al. Comparison between cerebral tissue oxygen tension and energy metabolism in experimental subdural hematoma. Neurocritical Care. (2011) 15:585–92. doi: 10.1007/s12028-011-9563-2

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Timaru-Kast R, Meissner A, Heimann A, Hoelper B, Kempski O, Alessandri B. Acute subdural hematoma in pigs: role of volume on multiparametric neuromonitoring and histology. J Neurotrauma. (2008) 25:1107–19. doi: 10.1089/neu.2008.0517

PubMed Abstract | CrossRef Full Text | Google Scholar

17. De Lanerolle NC, Bandak F, Kang D, Li AY, Du F, Swauger P, et al. Characteristics of an explosive blast-induced brain injury in an experimental model. J Neuropathol Exp Neurol. (2011) 70:1046–57. doi: 10.1097/NEN.0b013e318235bef2

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Kim B, Haque A, Arnaud FG, Teranishi K, Steinbach T, Auker CR, et al. Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury. J Emerg Trauma Shock. (2014) 7:102–11. doi: 10.4103/0974-2700.130880

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Lafrenaye AD, Todani M, Walker SA, Povlishock JT. Microglia processes associate with diffusely injured axons following mild traumatic brain injury in the micro pig. J Neuroinflam. (2015) 12:186. doi: 10.1186/s12974-015-0405-6

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Smith DH, Chen XH, Xu BN, McIntosh TK, Gennarelli TA, Meaney DF. Characterization of diffuse axonal pathology and selective hippocampal damage following inertial brain trauma in the pig. J Neuropathol Exp Neurol. (1997) 56:822–34. doi: 10.1097/00005072-199756070-00009

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Trautz F, Franke H, Bohnert S, Hammer N, Müller W, Stassart R, et al. Survival-time dependent increase in neuronal IL-6 and astroglial GFAP expression in fatally injured human brain tissue. Sci Rep. (2019) 9:11771. doi: 10.1038/s41598-019-48145-w

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Nagahara N, Ito T, Kitamura H, Nishino T. Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: confocal laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis. Histochem Cell Biol. (1998) 110:243–50. doi: 10.1007/s004180050286

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. (2017) 80:6–15. doi: 10.1227/NEU.0000000000001432

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Merz T, Wepler M, Nußbaum B, Vogt J, Calzia E, Wang R, et al. Cystathionine-γ-lyase expression is associated with mitochondrial respiration during sepsis-induced acute kidney injury in swine with atherosclerosis. Intensive Care Med Exp. (2018) 6:43. doi: 10.1186/s40635-018-0208-z

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Graham DI. Pathology of hypoxic brain damage in man. J Clin Pathol. (1977) 11:170–80. doi: 10.1136/jcp.s3-11.1.170

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Brierley JB. Experimental hypoxic brain damage. J Clin Pathol. (1977) 11:181–7. doi: 10.1136/jcp.s3-11.1.181

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Veenith TV, Carter EL, Geeraerts T, Grossac J, Newcombe VF, Outtrim J, et al. Pathophysiologic mechanisms of cerebral ischemia and diffusion hypoxia in traumatic brain injury. JAMA Neurol. (2016) 73:542–50. doi: 10.1001/jamaneurol.2016.0091

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science (New York NY.). (2015) 347:1260419. doi: 10.1126/science.1260419

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Diwakar L, Ravindranath V. Inhibition of cystathionine-gamma-lyase leads to loss of glutathione aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem Int. (2007) 50:418–26. doi: 10.1016/j.neuint.2006.09.014

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Paul BD, Sbodio JI, Xu R, Vandiver MS, Cha JY, Snowman AM, et al. Cystathionine γ-lyase deficiency mediates neurodegeneration in huntington's disease. Nature. (2014) 509:96–100. doi: 10.1038/nature13136

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Lee M, Schwab C, Yu S, McGeer E, McGeer PL. Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging. (2009) 30:1523–34. doi: 10.1016/j.neurobiolaging.2009.06.001

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Leffler CW, Parfenova H, Basuroy S, Jaggar JH, Umstot ES, Fedinec AL. Hydrogen sulfide and cerebral microvascular tone in newborn pigs. Am J Physiol Heart Circ Physiol. (2011) 300:H440–47. doi: 10.1152/ajpheart.00722.2010

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Patel S, Fedinec AL, Liu J, Weiss MA, Pourcyrous M, Harsono M, et al. H2S mediates the vasodilator effect of endothelin-1 in the cerebral circulation. Am J Physiol Heart Circ Physiol. (2018) 315:H1759–64. doi: 10.1152/ajpheart.00451.2018

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Kanaumi T, Ichinohe A, Kimura H, Iwasaki H, Hirose S, Takshima S. Development and aging expression of cystathionine-beta synthase in the temporal lobe and cerebellum of down syndrome patients. Neuroembryol Aging. (2006) 4:202–7. doi: 10.1159/000118930

CrossRef Full Text | Google Scholar

35. Coletti R, Almeida-Pereira G, Elias LL, Antunes-Rodrigues J. Effects of hydrogen sulfide (H2S) on water intake and vasopressin and oxytocin secretion induced by fluid deprivation. Horm Behav. (2015) 67:12–20. doi: 10.1016/j.yhbeh.2014.11.008

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Boccia ML, Petrusz P, Suzuki K, Marson L, Pedersen CA. Immunohistochemical localization of oxytocin receptors in human brain. Neuroscience. (2013) 253:155–64. doi: 10.1016/j.neuroscience.2013.08.048

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Raymond AD, Kucherepa NN, Fisher KR, Halina WG, Partlow GD. Neurogenesis of oxytocin-containing neurons in the paraventricular nucleus (PVN) of the female pig in 3 reproductive states: puberty gilts, adult gilts and lactating sows. Brain Res. (2006) 1102:44–51. doi: 10.1016/j.brainres.2006.04.113

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Rankin SL, Partlow GD, McCurdy RD, Giles ED, Fisher KR. Postnatal neurogenesis in the vasopressin and oxytocin-containing nucleus of the pig hypothalamus. Brain Res. (2003) 971:189–96. doi: 10.1016/S0006-8993(03)02350-3

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Merz T, Denoix N, Wigger D, Waller C, Wepler M, Vettorazzi S, et al. The role of glucocorticoid receptor and oxytocin receptor in the septic heart in a clinically relevant, resuscitated porcine model with underlying atherosclerosis. Front Endocrinol. (2020) 11:299. doi: 10.3389/fendo.2020.00299

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Wang Y, Jia J, Ao G, Hu L, Liu H, Xiao Y, et al. Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia. J Neurochem. (2014) 129:827–38. doi: 10.1111/jnc.12695

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Li H, Zhu L, Feng J, Hu X, Li C, Zhang B. Hydrogen sulfide decreases blood-brain barrier damage via regulating protein kinase c and tight junction after cardiac arrest in rats. Cell Physiol Biochem. (2018) 47:994–1006. doi: 10.1159/000490166

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Geng Y, Li E, Mu Q, Zhang Y, Wei X, Li H, et al. Hydrogen sulfide inhalation decreases early blood-brain barrier permeability and brain edema induced by cardiac arrest and resuscitation. J Cereb Blood Flow Metab. (2015) 35:494–500. doi: 10.1038/jcbfm.2014.223

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Tabernero A, Granda B, Medina A, Sánchez-Abarca LI, Lavado E, Medina JM. Albumin promotes neuronal survival by increasing the synthesis and release of glutamate. J Neurochem. (2002) 81:881–91. doi: 10.1046/j.1471-4159.2002.00843.x

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Johnson VE, Weber MT, Xiao R, Cullen DK, Meaney DF, Stewart W, et al. Mechanical disruption of the blood-brain barrier following experimental concussion. Acta Neuropathol. (2018) 135:711–26. doi: 10.1007/s00401-018-1824-0

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Philips T, Rothstein JD. Oligodendroglia: metabolic supporters of neurons. J Clin Invest. (2017) 127:3271–80. doi: 10.1172/JCI90610

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Dimou L, Simon C, Kirchhoff F, Takebayashi H, Götz M. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J Neurosci. (2008) 28:10434–42. doi: 10.1523/JNEUROSCI.2831-08.2008

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Lagraoui M, Sukumar G, Latoche JR, Maynard SK, Dalgard CL, Schaefer BC. Salsalate treatment following traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant functional recovery. Brain Behav Immun. (2017) 61:96–109. doi: 10.1016/j.bbi.2016.12.005

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Ahn SM, Byun K, Cho K, Kim JY, Yoo JS, Kim D, et al. Human microglial cells synthesize albumin in brain. PLoS ONE. (2008) 3:e2829. doi: 10.1371/journal.pone.0002829

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Prajapati KD, Sharma SS, Roy N. Upregulation of albumin expression in focal ischemic rat brain. Brain Res. (2010) 1327:118–24. doi: 10.1016/j.brainres.2010.02.063

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Goette A, Bukowska A, Dobrev D, Pfeiffenberger J, Morawietz H, Strugala D, et al. Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J. (2009) 30:1411–20. doi: 10.1093/eurheartj/ehp046

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Schwarz H, Jagla W, Wiede A, Hoffmann W. Ultrastructural co-localization of TFF3-peptide and oxytocin in the neural lobe of the porcine pituitary. Cell Tissue Res. (2001) 305:411–16. doi: 10.1007/s004410100412

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Bonnet D, Garcia M, Vecino E, Lorentz JG, Sahel J, Hicks D. Brain-derived neurotrophic factor signalling in adult pig retinal ganglion cell neurite regeneration in vitro. Brain Res. (2004) 1007:142–51. doi: 10.1016/j.brainres.2004.02.023

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Schook L, Beattie C, Beever J, Donovan S, Jamison R, Zuckermann F, et al. Swine in biomedical research: creating the building blocks of animal models. Anim Biotechnol. (2005) 16:183–90. doi: 10.1080/10495390500265034

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Fairbairn L, Kapetanovic R, Sester DP, Hume DA. The mononuclear phagocyte system of the pig as a model for understanding human innate immunity and disease. J Leukocyte Biol. (2011) 89:855–71. doi: 10.1189/jlb.1110607

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Fukuda AM, Badaut J. Aquaporin 4: a player in cerebral edema and neuroinflammation. J Neuroinflam. (2012) 9:279. doi: 10.1186/1742-2094-9-279

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Buriticá E, Villamil L, Guzmán F, Escobar MI, García-Cairasco N, Pimienta HJ. Changes in calcium-binding protein expression in human cortical contusion tissue. J Neurotrauma. (2009) 26:2145–55. doi: 10.1089/neu.2009.0894

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Hammad A, Westacott L, Zaben M. The role of the complement system in traumatic brain injury: a review. J Neuroinflam. (2018) 15:24. doi: 10.1186/s12974-018-1066-z

CrossRef Full Text | Google Scholar

58. Stahel PF, Morganti-Kossmann MC, Kossmann T. The role of the complement system in traumatic brain injury. Brain Res. Rev. (1998) 27:243–56. doi: 10.1016/S0165-0173(98)00015-0

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Roselli F, Karasu E, Volpe C, Huber-Lang M. Medusa's head: the complement system in traumatic brain and spinal cord injury. J Neurotrauma. (2018) 35:226–40. doi: 10.1089/neu.2017.5168

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Mahajan SD, Parikh NU, Woodruff TM, Jarvis JN, Lopez M, Hennon T, et al. C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus. Immunology. (2015) 146:130–43. doi: 10.1111/imm.12489

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Zhou X, Chu X, Xin D, Li T, Bai X, Qiu J, et al. L-cysteine-derived H2S promotes microglia M2 polarization via activation of the AMPK pathway in hypoxia-ischemic neonatal mice. Front Mol Neurosci. (2019) 12:58. doi: 10.3389/fnmol.2019.00058

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Blecharz-Lang KG, Wagner J, Fries A, Nieminen-Kelhä M, Rösner J, Schneider UC, et al. Interleukin 6-mediated endothelial barrier disturbances can be attenuated by blockade of the IL6 receptor expressed in brain microvascular endothelial cells. Transl Stroke Res. (2018) 9:631–42. doi: 10.1007/s12975-018-0614-2

PubMed Abstract | CrossRef Full Text | Google Scholar

63. März P, Gadient RA, Otten U. Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha). Brain Res. (1996) 706:71–79. doi: 10.1016/0006-8993(95)01210-9

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Timper K, Denson JL, Steculorum SM, Heilinger C, Engström-Ruud L, Wunderlich CM, et al. IL-6 improves energy and glucose homeostasis in obesity via enhanced central IL-6 trans-signaling. Cell Rep. (2017) 19:267–80. doi: 10.1016/j.celrep.2017.03.043

PubMed Abstract | CrossRef Full Text | Google Scholar